Pharmacogenomics holds promise for personalized dementia therapies

Pharmacogenomics-based studies in the research for personalized therapeutics for dementia

Clinical Challenges: Helping Patients Navigate Safety Concerns of OTC Eye Drops

Artificial tears are the mainstay of dry eye disease (DED) management, and patients typically start by using over-the-counter (OTC) drops several times a day. But

November 28, 2023

FLT3 Inhibitor Highly Active in Newly Diagnosed Acute Myeloid Leukemia

Patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) had a high response rate and prolonged event-free survival (EFS) following treatment with an investigational FLT3

February 14, 2024

Funding instability plagues program that brings docs to underserved areas

For Diana Perez, a medical resident at the Family Health Center of Harlem, the handwritten thank-you note she received from a patient is all the

June 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.